<DOC>
	<DOCNO>NCT01840085</DOCNO>
	<brief_summary>To evaluate safety topical 0.03 % DSC127 Gel use one continuous treatment period chronic Wagner Grade 1 2 foot ulcer ( target ulcer ) multiple ulcer diabetic subject . The maximum duration treatment period 24 week .</brief_summary>
	<brief_title>Open-Label Study Diabetic Foot Ulcers ( DFU ) , Evaluate Safety 0.03 % DSC127 Topical Gel Chronic Use</brief_title>
	<detailed_description>All eligible subject enrol begin daily Treatment topical 0.03 % DSC127 gel complete wound closure ( defined skin re-epithelialization without drainage dress requirement ) 24 week , whichever occur first . If patient multiple ulcer one foot , may treat , within maximum 24 week . If ulcer heal , wash period 1 week , new treatment period 24 week may initiate . Ulcer may retreat recur new ulcer develop meet study criterion . For entire duration treatment period standard care DFU maintain .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1 . Male female ambulatory subject least 18 year age screen 2 . Have least one ulcer : 1. chronic ( present &gt; 1month ) 2 . Wagner Grade 1 Grade 2 ulcer ( i.e . Partial full thickness involve bone , tendon capsule ( probe tendon capsule ) and/or penetrate tendon capsule . ) 3. sign infection osteomyelitis , 4. locate malleolus . 3 . Have ABI &gt; 0.7 , TcPO2 &gt; 40 mm Hg great toe systolic pressure &gt; 50 mmHg ensure heal potential . 4 . Have Type I Type II diabetes metabolic control confirm glycosylated hemoglobin ( HbA1c ) ≤ 14 % , obtain enrollment within 30 day prior study enrollment . 5 . Female subject childbearing potential must negative pregnancy test time enrollment initiation study treatment period . 6 . Female subject childbearing potential must willing use medically acceptable method birth control , Essure® , hormonal contraception ( oral pill , implantable device skin patch ) , intrauterine device , tubal ligation , double barrier , abstinence treatment period study participation . 7 . Ability willingness understand comply study procedure give write informed consent prior enrollment study initiation study procedures 1 . Has know hypersensitivity study medication component . 2 . Exposure investigational product within 30 day entry study . 3 . Has active malignant disease kind ( exception basal cell carcinoma ) . A subject , malignant disease past , treat currently diseasefree , may consider study entry . Diseasefree define remission least 5 year . 4 . Chronic liver dysfunction evidence transaminase level &gt; 2.5 time high upper level normal two occasion . 5 . Has history additional risk factor TdP ( eg . heart failure , hypokalemia , family history Long QT Syndrome ) take medication know prolong QT/QTc ( Appendix G ) 6 . Receiving hemodialysis chronic ambulatory peritoneal dialysis ( CAPD ) therapy . 7 . Prior radiation therapy foot ulcer study . 8 . Current use systemic corticosteroid immunosuppressant within 8 week prior enrollment study 9 . Sicklecell anemia , Raynaud 's peripheral vascular disease . 10 . Subjects receive biologic agent include growth factor skin equivalent ( Regranex , Apligraft , Dermagraft ) 7 day prior exposure DSC127 . 11 . Subject , opinion investigator , uncontrolled hypertension 12 . Subject ulcer determine clinically infect require antimicrobial agent know affect wound heal take systemic antibiotic 7 day reason . ( Subjects infection initial visit Screening Period rescreened three week later single course antibiotic therapy ( occur concurrently within three week initial visit , antibiotic treatment must complete washout ( 7 day ) must elapse ) ; time infection still present , subject exclude . ) 13 . Subjects , opinion investigator , clinically significant anemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Diabetic foot ulcer</keyword>
	<keyword>plantar neuropathic ulcer</keyword>
	<keyword>plantar neuroischemic ulcer</keyword>
	<keyword>Wagner Grade 1 Grade 2 DFU</keyword>
</DOC>